Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Methods The objective of this document has been to develop handy and clinically relevant
recommendations on schistosomiasis screening, diagnosis and treatment useful for a broad …

Abstract SPHK1 (sphingosine kinase type 1) is characterized as a rate-limiting enzyme in
sphingolipid metabolism to phosphorylate sphingosine into sphingosine-1-phosphate (S1P) …

Nanoformulations are regarded as a promising tool to enable the efficient delivery of active
pharmaceutical ingredients to the target site. One of the best-known and most studied …

With the advent of next generation sequencing, it is now appreciated that human urine is not
sterile. Recent investigations of the urinary microbiome (urobiome) have provided insights …

Urogenital schistosomiasis is caused by Schistosoma haematobium (S. haematobium)
infection, which has been linked to the development of bladder cancer. In this study, three …

Schistosomiasis, a parasitic disease caused by Schistosoma spp., affects more than 250
million people worldwide. S. mansoni in particular affects the gastrointestinal tract and …

Local-regional failure for patients with≥ pT3 urothelial carcinoma after radical cystectomy is
a significant clinical challenge. Prospective randomised trials have failed to show that …

Introduction: Schistosomiasis, a tropical disease affecting humans and animals, affected
251.4 million people in 2021. Schistosoma mansoni, S. haematobium, S. intercalatum, and …

Global cancer surgery is an essential and complex component of oncologic care. This study
aims to describe global cancer surgery literature since the 2015 Lancet Commission on …